pancreatic cancer

You have access
Prognostic Value and the Immune Microenvironment-associated Role of SMAD4 in Pancreatic Adenocarcinoma
YIRAN SONG, YANG WANG, TIANYU YU, YAZHI HE, CHUNYAN WANG, FENG WANG and YINGQUN ZHOU

Anticancer Research December 2023, 43 (12) 5393-5408; DOI: https://doi.org/10.21873/anticanres.16743
You have access
PARP Inhibitor Sensitizes BRCA-mutant Pancreatic Cancer to Oxaliplatin by Suppressing the CDK1/BRCA1 Axis
CHORONG KIM, DANBEE KIM, DA SOL LEE, SEONMIN LEE, CHANGHOON YOO and KYU-PYO KIM

Anticancer Research December 2023, 43 (12) 5523-5534; DOI: https://doi.org/10.21873/anticanres.16754
Open Access
High Glucose-stimulated aPKC Activation Promotes Pancreatic Cancer Cell Progression Through YAP Signaling
TEPPEI SUNAGUCHI, YOSUKE HORIKOSHI, TAKEHIKO HANAKI, TERUHISA SAKAMOTO, KAZUHIRO NAKASO, CHIEKO SAKAI, KAZUNARI YAMASHITA, SHIGEO OHNO, YOSHIYUKI FUJIWARA and TATSUYA MATSURA

Anticancer Research November 2023, 43 (11) 4843-4853; DOI: https://doi.org/10.21873/anticanres.16681
You have access
Over-expression of cFos by the Transcription Factors NFATc2 and Sp1 in Pancreatic Cancer Cells
MANUELA MALSY, BERNHARD GRAF, ELISABETH BRUENDL, CONSTANTIN MAIER-STOCKER and ANIKA BUNDSCHERER

Anticancer Research November 2023, 43 (11) 4897-4904; DOI: https://doi.org/10.21873/anticanres.16687
You have access
Sociodemographic Barriers to the Timely Treatment of Pancreatic Cancer
PAOLA BERRIOS JIMENEZ, REED POPP, SEEMA SHARAN, HARSHEEN K. MANAISE, SYEDA HOORULAIN AHMED, SHIVAM BANSAL, GABRIELLE KOWKABANY, SWATHI RAIKOT, KULKAEW BELLE SUKNIAM DO, ANTHONY GEORGE and EMMANUEL GABRIEL

Anticancer Research November 2023, 43 (11) 4969-4974; DOI: https://doi.org/10.21873/anticanres.16695
You have access
miR-122-5p Restrains Pancreatic Cancer Cell Growth and Causes Apoptosis by Negatively Regulating ASCT2
PING REN, NA WU, SHICHEN FU, WENBIN WANG, QI LI and QINGZHOU CHENG

Anticancer Research October 2023, 43 (10) 4379-4388; DOI: https://doi.org/10.21873/anticanres.16634
Open Access
Clinical Impact of Nutrition and Inflammation Assessment Tools in Pancreatic Cancer Treatment
TORU AOYAMA, YUKIO MAEZAWA, ITARU HASHIMOTO, YASUSHI RINO and TAKASHI OSHIMA

Anticancer Research September 2023, 43 (9) 3849-3860; DOI: https://doi.org/10.21873/anticanres.16572
You have access
FOLFIRINOX in Pancreatic Cancer: Risk Factors for Febrile Neutropenia and Severe Neutropenia — Nationwide Study Analysis
AKIKO TODAKA, MITSUHITO SASAKI, HIDEKI UENO, TAKUMA GOTO, GOU MUROHISA, NOBUMASA MIZUNO, MASATO OZAKA, SATOSHI KOBAYASHI, KAZUHIRO UESUGI, NORITOSHI KOBAYASHI, HIDEYUKI HAYASHI, KENTARO SUDO, NAOHIRO OKANO, YOSUKE HORITA, KEIKO KAMEI, SHOKO NANAMI and NARIKAZU BOKU

Anticancer Research September 2023, 43 (9) 4115-4123; DOI: https://doi.org/10.21873/anticanres.16601
You have access
High Preoperative Serum D-dimer Predicts Unfavorable Survival Outcomes for Pancreatic Cancer Patients
TOMOHISA OTSU, MASAMICHI HAYASHI, HIDEKI TAKAMI, YOSHIKUNI INOKAWA, NOBUTAKE TANAKA, KEISUKE KURIMOTO, KOKI NAKANISHI, SHINICHI UMEDA, DAI SHIMIZU, NORIFUMI HATTORI, MITSURO KANDA, CHIE TANAKA, GORO NAKAYAMA and YASUHIRO KODERA

Anticancer Research July 2023, 43 (7) 3173-3181; DOI: https://doi.org/10.21873/anticanres.16491
Open Access
KRAS Mutation Analysis Using Cell-free DNA of Pancreatic Cancer
YORIHIKO TAKASE, YOSHIKI NAITO, AKIHIKO KAWAHARA, YOSHINOBU OKABE, EIJI SADASHIMA, HIDEYUKI ABE and JUN AKIBA

Anticancer Research June 2023, 43 (6) 2683-2690; DOI: https://doi.org/10.21873/anticanres.16434

Main menu

User menu

Search

pancreatic cancer

Pages